Funding will help expand distribution and bring new GMO probiotics to market that solve modern-day problems for health-conscious consumers

August 27, 2024 09:04 AM Eastern Daylight Time

SAN FRANCISCO–(BUSINESS WIRE)–ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led by Spring Tide Capital. The oversubscribed round also includes participation by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures. The company will use the funds to meet growing consumer demand, spearhead retail expansion, and drive continued research and development in a new sector, including bringing new genetically engineered probiotic products to market that address the unique and newly arising biological challenges of modern living.

“Off of the breakout success of their first product, ZBiotics has more than doubled sales every year, selling over 5 million units cumulatively and reaching company-wide profitability in 2023”Post this

Created and led by a team of Ph.D. scientists passionate about bringing new functionality to the human body and augmenting existing functions, ZBiotics employs a new kind of genetic engineering: transparent, responsible, and built directly for consumers. Leveraging modern biotechnology, the company helps consumers actively engage in living healthier lives by creating genetically engineered probiotics for specific use cases that solve modern-day, real-world problems. The company’s flagship product, Pre-Alcohol Probiotic Drink, mimics the function of the liver by breaking down the toxic byproduct of alcohol, acetaldehyde, helping consumers feel better the day after drinking.

“Genetic engineering allows us to make totally new products that address real-world consumer needs, and we’re witnessing a growing interest in our technology and brand,” stated Zack Abbott, Ph.D., co-founder and CEO of ZBiotics. “In a market that craves real solutions, we’ve shown that being a proudly GMO company prioritizing transparency resonates with consumers, driving ZBiotics’ momentum. With these funds, we aim to meet demand and expand the ZBiotics product line beyond our flagship product.”

ZBiotics is trailblazing a new frontier by marrying biotechnology with consumer goods to solve problems that previously only had band-aid solutions. Fundamentally driven by the mission of making people healthier through modern biotechnology, ZBiotics has created a company that provides consumers with sustainable, effective solutions that cannot and do not exist without genetic engineering.

“Off of the breakout success of their first product, ZBiotics has more than doubled sales every year, selling over 5 million units cumulatively and reaching company-wide profitability in 2023,” said Adam Ramada, co-managing partner of Spring Tide Capital. “We are thrilled to support the team as they continue to expand their revolutionary probiotic platform across many more exciting use cases that address everyday consumer pain points.”

ZBiotics will utilize the funds from its Series A round to develop and bring additional use-case probiotics to market, leveraging the same technology used to develop its Pre-Alcohol Probiotic Drink to create additional solutions for consumers looking to prioritize different aspects of their health. In addition to its flagship product, the company will be launching its second product in the coming weeks, which will focus on microbial diversity in the gut and associated benefits. Research and development at ZBiotics is also actively exploring products that will address a range of concerns like sleep, vaginal health and athletic performance. The funds will also be used to launch the ZBiotics brand into physical retail spaces, aligning with the long-term vision of the company to make “proudly GMO” products more accessible to the consumers who benefit from their solutions.

About ZBiotics

ZBiotics is the world’s first maker of genetically engineered probiotics, purpose-built to improve our health, starting with helping our bodies handle the unique and newly arising biological challenges of modern living. Developed by CEO and co-founder Zack Abbott, Ph.D., the company’s flagship product breaks down acetaldehyde, an unwanted byproduct of alcohol associated with the day-after effects of drinking. ZBiotics makes products for consumers who want to live healthier lives and take a more active role in their well-being. A bioengineering company, ZBiotics employs the power of engineered probiotics to bring new functionality to the human body or to augment existing functions. It’s a new kind of genetic engineering: transparent, responsible, and built directly for consumers. Find out more at ZBiotics.com or follow ZBiotics on Instagram, X, Linkedin, or YouTube.

Contacts

Media Contact:
Jack Taylor PR

(c)2024 Business Wire, Inc., All rights reserved.